Global Value Dossier (GVD)

Evidence-Based Medicine (EBM) is central to reimbursement applications and HTA submissions worldwide; new products must prove their clinical and cost benefits in comparison to current therapy.

A Global Value Dossier (GVD) forms the basis of evidence to serve internal and external communications, and regulatory submissions (HTA organizations)

GVD is a complete information resource that distinctly communicates product value. It contains a value proposition supported by value statements, which are supported by clinical, economic, and humanistic data from clinical studies, published literature, economic models, etc.

A GVD is a tool with the following functions:

  • Customize submissions to payers
  • Train your staff (reimbursement, marketing, health economics, global staff)
  • Detect gaps in your data and plan for further studies
  • Summarize the burden of illness of the condition your product treats
  • Demonstrate how your product can solve an unmet need in the market

We effectively communicate clinical and economic value of your product to ensure reimbursement from the following agencies:

  • PBAC
  • NICE
  • US managed care
  • NHS
  • AMCP